3839 Stock Overview
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Chia Tai Enterprises International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.68 |
| 52 Week High | HK$2.30 |
| 52 Week Low | HK$0.65 |
| Beta | 3.3 |
| 1 Month Change | -16.05% |
| 3 Month Change | -24.44% |
| 1 Year Change | -60.47% |
| 3 Year Change | -59.52% |
| 5 Year Change | -65.31% |
| Change since IPO | -88.09% |
Recent News & Updates
Not Many Are Piling Into Chia Tai Enterprises International Limited (HKG:3839) Just Yet
Feb 15
Be Wary Of Chia Tai Enterprises International (HKG:3839) And Its Returns On Capital
Dec 21Recent updates
Not Many Are Piling Into Chia Tai Enterprises International Limited (HKG:3839) Just Yet
Feb 15Be Wary Of Chia Tai Enterprises International (HKG:3839) And Its Returns On Capital
Dec 21These 4 Measures Indicate That Chia Tai Enterprises International (HKG:3839) Is Using Debt Extensively
Oct 10Returns Are Gaining Momentum At Chia Tai Enterprises International (HKG:3839)
Aug 22Does Chia Tai Enterprises International (HKG:3839) Have A Healthy Balance Sheet?
Jun 07There's Been No Shortage Of Growth Recently For Chia Tai Enterprises International's (HKG:3839) Returns On Capital
Apr 17Chia Tai Enterprises International (HKG:3839) Seems To Use Debt Quite Sensibly
Jan 30We Think That There Are More Issues For Chia Tai Enterprises International (HKG:3839) Than Just Sluggish Earnings
Oct 05Chia Tai Enterprises International's (HKG:3839) Returns On Capital Not Reflecting Well On The Business
Jul 25Is Chia Tai Enterprises International (HKG:3839) A Risky Investment?
Jan 18Chia Tai Enterprises International (HKG:3839) Seems To Use Debt Quite Sensibly
Sep 08Does Chia Tai Enterprises International (HKG:3839) Have A Healthy Balance Sheet?
Apr 26The Returns At Chia Tai Enterprises International (HKG:3839) Provide Us With Signs Of What's To Come
Feb 28We Think Chia Tai Enterprises International (HKG:3839) Is Taking Some Risk With Its Debt
Jan 24
Chia Tai Enterprises International's (HKG:3839) Stock Price Has Reduced 38% In The Past Five Years
Dec 02Shareholder Returns
| 3839 | HK Food | HK Market | |
|---|---|---|---|
| 7D | 1.5% | 3.7% | 3.6% |
| 1Y | -60.5% | -23.3% | -10.1% |
Return vs Industry: 3839 underperformed the Hong Kong Food industry which returned -23.3% over the past year.
Return vs Market: 3839 underperformed the Hong Kong Market which returned -10.9% over the past year.
Price Volatility
| 3839 volatility | |
|---|---|
| 3839 Average Weekly Movement | 7.6% |
| Food Industry Average Movement | 6.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 3839's share price has been volatile over the past 3 months.
Volatility Over Time: 3839's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,000 | n/a | www.ctei.com.hk |
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands.
Chia Tai Enterprises International Limited Fundamentals Summary
| 3839 fundamental statistics | |
|---|---|
| Market cap | HK$163.69m |
| Earnings (TTM) | HK$20.00m |
| Revenue (TTM) | HK$1.36b |
8.2x
P/E Ratio0.1x
P/S RatioIs 3839 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3839 income statement (TTM) | |
|---|---|
| Revenue | US$173.98m |
| Cost of Revenue | US$140.21m |
| Gross Profit | US$33.77m |
| Other Expenses | US$31.21m |
| Earnings | US$2.55m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 19.41% |
| Net Profit Margin | 1.47% |
| Debt/Equity Ratio | 31.0% |
How did 3839 perform over the long term?
See historical performance and comparison